Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2025-12-27 @ 2:00 PM
Study NCT ID:
NCT03961568
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-06-11
First Post:
2019-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cenobamate Open-Label Extension Study for YKP3089C025
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'C562694', 'term': 'Epilepsy, Idiopathic Generalized'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C000654784', 'term': 'Cenobamate'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 145}}, 'statusModule': {'overallStatus': 'ENROLLING_BY_INVITATION', 'startDateStruct': {'date': '2019-08-13', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-12', 'completionDateStruct': {'date': '2026-08', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-06-09', 'studyFirstSubmitDate': '2019-05-21', 'studyFirstSubmitQcDate': '2019-05-21', 'lastUpdatePostDateStruct': {'date': '2025-06-11', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2019-05-23', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-08', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Incidence of Adverse Events and SAEs', 'timeFrame': '386 +/- 2 days', 'description': 'Summary statistics for clinical laboratory test results and vital signs; and physical examination, neurologic examination and electrocardiogram (ECG) finding.'}]}, 'oversightModule': {'isUsExport': False, 'oversightHasDmc': True, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Idiopathic Generalized Epilepsy'], 'conditions': ['Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy']}, 'descriptionModule': {'briefSummary': '52 Week Open-Label Safety Study of Cenobamate for Subjects who Complete YKP3089C025 (core study)', 'detailedDescription': '52 Week Open-Label Safety Study of cenobamate adjunctive therapy for subjects who complete double-blind study YKP3089C025. Subjects will have a 12 week double-blind conversion phase where subjects who received placebo in the double-blind study will be converted to cenobamate. Subjects who received cenobamate in the double-blind study will continue to receive their daily dose of cenobamate. Subjects switching from placebo to cenobamate will be titrated starting at 12.5 mg and increase their dose over the course of 12 weeks as follows 12.5 mg for 2 weeks, 25 mg for two weeks, 50 mg for two weeks, 100 mg for two weeks, 150 mg for two weeks, and 200 mg for two weeks. All subjects will receive 200 mg for the last two weeks of the conversion phase to preserve the blind. After completing the double-blind conversion phase, subjects will have 40 weeks of open-label, flexibly dosed cenobamate. The dose range is 50 mg - 200 mg. Primary endpoints are all safety measures.\n\nAdolescents will follow the same every two week regimen and receive cenobamate as an oral suspension based on weight'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'minimumAge': '12 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* The subject must have successfully completed the Double-blind Treatment Period in the Core study.\n* Written informed consent signed by the subject or legal guardian, prior to entering the study, in accordance with the International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guidelines. If the written informed consent is provided by the legal guardian because the subject is unable to do so, a written or verbal assent from the subject must also be obtained. As required by country-specific regulations, only the subject may sign the ICF in accordance with ICH guidelines.\n\nExclusion Criteria:\n\n* Subject tests positive, via urine drug screen at Visit 14 of the Core study, for illicit drugs except for tetrahydrocannabinol and Cannabinoids.\n* Any significant changes to the subject's medical history that, in the opinion of the Principal Investigator, could affect the subject's safety or conduct of the study."}, 'identificationModule': {'nctId': 'NCT03961568', 'briefTitle': 'Cenobamate Open-Label Extension Study for YKP3089C025', 'organization': {'class': 'INDUSTRY', 'fullName': 'SK Life Science, Inc.'}, 'officialTitle': 'A Multicenter Open-Label Extension Study to Evaluate the Long-Term Safety of Cenobamate Adjunctive Therapy in Subjects With Primary Generalized Tonic-Clonic Seizures', 'orgStudyIdInfo': {'id': 'YKP3089C033'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Core Study Placebo', 'description': 'Subjects who did not receive Cenobamate in the Core Study will receive Cenobamate 12.5 mg tablet once a day for two weeks, 25 mg tablet once a day for two weeks, 50 mg tablet once a day for two weeks, 100 mg tablets once a day for two weeks, 150 mg tablets once a day for two weeks and 200 mg tablets once a day for twelve weeks.\n\nAdolescents will follow the same every two week regimen and receive cenobamate as an oral suspension based on weight.', 'interventionNames': ['Drug: Cenobamate']}, {'type': 'EXPERIMENTAL', 'label': 'Core Study Active', 'description': 'Subjects who received cenobamate in the Core study will continue to receive the same daily dose (150 mg or 200mg).\n\nAdolescents will follow the same every two week regimen and receive cenobamate as an oral suspension based on weight.', 'interventionNames': ['Drug: Cenobamate']}], 'interventions': [{'name': 'Cenobamate', 'type': 'DRUG', 'otherNames': ['YKP3089'], 'description': 'active drug', 'armGroupLabels': ['Core Study Active', 'Core Study Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': '92093', 'city': 'La Jolla', 'state': 'California', 'country': 'United States', 'facility': 'University of California, San Diego (UCSD)', 'geoPoint': {'lat': 32.84727, 'lon': -117.2742}}, {'zip': '33176', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'The Neurology Research Group, LLC.', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33606', 'city': 'Tampa', 'state': 'Florida', 'country': 'United States', 'facility': 'University of South Florida', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '96814', 'city': 'Honolulu', 'state': 'Hawaii', 'country': 'United States', 'facility': 'Hawaii Pacific Neuroscience', 'geoPoint': {'lat': 21.30694, 'lon': -157.85833}}, {'zip': '83702', 'city': 'Boise', 'state': 'Idaho', 'country': 'United States', 'facility': 'Consultants in Epilepsy and Neurology, PLLC', 'geoPoint': {'lat': 43.6135, 'lon': -116.20345}}, {'zip': '04074', 'city': 'Scarborough', 'state': 'Maine', 'country': 'United States', 'facility': 'Maine Medical Center', 'geoPoint': {'lat': 43.57814, 'lon': -70.32172}}, {'zip': '20817', 'city': 'Bethesda', 'state': 'Maryland', 'country': 'United States', 'facility': 'Mid-Atlantic Epilepsy and Sleep Center', 'geoPoint': {'lat': 38.98067, 'lon': -77.10026}}, {'zip': '55422', 'city': 'Golden Valley', 'state': 'Minnesota', 'country': 'United States', 'facility': 'Minneapolis Clinic of Neurology', 'geoPoint': {'lat': 45.00969, 'lon': -93.34912}}, {'zip': '01056', 'city': 'Rochester', 'state': 'Minnesota', 'country': 'United States', 'facility': 'Mayo Clinic - Rochester', 'geoPoint': {'lat': 44.02163, 'lon': -92.4699}}, {'zip': '01074', 'city': 'Columbia', 'state': 'Missouri', 'country': 'United States', 'facility': 'University of Missouri Medical School', 'geoPoint': {'lat': 38.95171, 'lon': -92.33407}}, {'zip': '07601', 'city': 'Hackensack', 'state': 'New Jersey', 'country': 'United States', 'facility': 'Northeast Regional Epilepsy Group', 'geoPoint': {'lat': 40.88593, 'lon': -74.04347}}, {'zip': '11598', 'city': 'Woodmere', 'state': 'New York', 'country': 'United States', 'facility': 'Five Towns Neuroscience Research', 'geoPoint': {'lat': 40.63205, 'lon': -73.71263}}, {'zip': '27705', 'city': 'Durham', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Duke University', 'geoPoint': {'lat': 35.99403, 'lon': -78.89862}}, {'zip': '19140', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'University of Pennsylvania', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '98057', 'city': 'Renton', 'state': 'Washington', 'country': 'United States', 'facility': 'Valley Medical Center', 'geoPoint': {'lat': 47.48288, 'lon': -122.21707}}, {'zip': '99204', 'city': 'Spokane', 'state': 'Washington', 'country': 'United States', 'facility': 'MultiCare Rockwood Neurology Center', 'geoPoint': {'lat': 47.65966, 'lon': -117.42908}}, {'zip': '2700', 'city': 'Blagoevgrad', 'state': 'Blagoevgrad', 'country': 'Bulgaria', 'facility': 'Multiprofile Hospital for Active Treatment Puls AD', 'geoPoint': {'lat': 42.01457, 'lon': 23.09804}}, {'zip': '1407', 'city': 'Sofia', 'state': 'Sofia', 'country': 'Bulgaria', 'facility': 'Acibadem City Clinic Multiprofile Hospital for Active Treatment Tokuda EAD'}, {'zip': '1408', 'city': 'Sofia', 'state': 'Sofia', 'country': 'Bulgaria', 'facility': 'Diagnostic Consultative Center Neoclinic EAD'}, {'zip': '9000', 'city': 'Varna', 'state': 'Varna', 'country': 'Bulgaria', 'facility': 'Diagnostic Consultative Center Equita EOOD', 'geoPoint': {'lat': 43.21912, 'lon': 27.91024}}, {'zip': '5000', 'city': 'Veliko Tarnovo', 'state': 'Veliko Tarnovo', 'country': 'Bulgaria', 'facility': 'Medical Center Medica Plus OOD', 'geoPoint': {'lat': 43.08124, 'lon': 25.62904}}, {'zip': '5100', 'city': 'Veliko Tarnovo', 'state': 'Veliko Tarnovo', 'country': 'Bulgaria', 'facility': 'Multiprofile Hospital for Active Treatment Sv. Ivan Rilski Gorna Oryahovitsa EOOD', 'geoPoint': {'lat': 43.08124, 'lon': 25.62904}}, {'zip': '708 52', 'city': 'Ostrava-Poruba', 'country': 'Czechia', 'facility': 'Cerebrovaskularni poradna'}, {'zip': '150 06', 'city': 'Prague', 'country': 'Czechia', 'facility': 'Fakultni nemocnice v Motole', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '160 00', 'city': 'Prague', 'country': 'Czechia', 'facility': 'Forbeli s.r.o.-Neurologicka ambulance', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '760 01', 'city': 'Zlín', 'country': 'Czechia', 'facility': 'Neurologicka ambulance', 'geoPoint': {'lat': 49.22645, 'lon': 17.67065}}, {'zip': '1083', 'city': 'Budapest', 'country': 'Hungary', 'facility': 'Semmelweis Egyetem I. Sz. Gyermekgyogyaszati Klinika', 'geoPoint': {'lat': 47.49835, 'lon': 19.04045}}, {'zip': '60-848', 'city': 'Poznan', 'state': 'Greater Poland Voivodeship', 'country': 'Poland', 'facility': 'Clinical Research Center Spólka z Ograniczona Odpowiedzialnoscia Medic-R sp. k.', 'geoPoint': {'lat': 52.40692, 'lon': 16.92993}}, {'zip': '31-209', 'city': 'Krakow', 'state': 'Lesser Poland Voivodeship', 'country': 'Poland', 'facility': 'Centrum Leczenia Padaczki i Migreny', 'geoPoint': {'lat': 50.06143, 'lon': 19.93658}}, {'zip': '01-868', 'city': 'Warsaw', 'state': 'Masovian Voivodeship', 'country': 'Poland', 'facility': 'Centrum Medyczne Pratia Warszawa', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '40-635', 'city': 'Katowice', 'state': 'Silesian Voivodeship', 'country': 'Poland', 'facility': 'Górnoslaskie Centrum Medyczne im. prof. Leszka Gieca Slaskiego Uniwersytetu Medycznego w Katowicach', 'geoPoint': {'lat': 50.2597, 'lon': 19.02173}}, {'zip': '974 04', 'city': 'Banská Bystrica', 'country': 'Slovakia', 'facility': 'MUDr. Beata Dupejova, neurologicka ambulancia, s.r.o.', 'geoPoint': {'lat': 48.73947, 'lon': 19.14932}}, {'zip': '085 01', 'city': 'Bardejov', 'country': 'Slovakia', 'facility': 'IN MEDIC s.r.o.', 'geoPoint': {'lat': 49.29175, 'lon': 21.27271}}, {'zip': '018 41', 'city': 'Dubnica nad Váhom', 'country': 'Slovakia', 'facility': 'Konzilium, s.r.o.', 'geoPoint': {'lat': 48.95981, 'lon': 18.16634}}, {'zip': '49027', 'city': 'Dnipro', 'state': 'Dnipropetrovsk Oblast', 'country': 'Ukraine', 'facility': 'Municipal Institution "Dnipropetrovsk City Clinical Hospital No16" of Dnipropetrovsk Regional Council', 'geoPoint': {'lat': 48.46664, 'lon': 35.04066}}, {'zip': '65025', 'city': 'Odesa', 'state': 'Odesa Oblast', 'country': 'Ukraine', 'facility': 'Municipal Institution Odesa Regional Clinical Hospital, Department of Cerebro-Vascular Diseases', 'geoPoint': {'lat': 46.48572, 'lon': 30.74383}}, {'zip': '88018', 'city': 'Uzhhorod', 'state': 'Zakarpattia Oblast', 'country': 'Ukraine', 'facility': 'Regional Clinical Center of Neurosurgery and Neurology "Uzhhorod National University"', 'geoPoint': {'lat': 48.6242, 'lon': 22.2947}}, {'zip': '69600', 'city': 'Zaporizhzhya', 'state': 'Zaporizhzhya', 'country': 'Ukraine', 'facility': 'Municipal Institution Zaporizhzhia Regional Clinical Hospital of Zaporizhzhia Regional Council', 'geoPoint': {'lat': 47.85167, 'lon': 35.11714}}, {'zip': '49005', 'city': 'Dnipro', 'country': 'Ukraine', 'facility': 'Communal Institution "Dnipropetrovsk Regional Clinical Hospital n.a. I.I. Mechnikov", Regional Center', 'geoPoint': {'lat': 48.46664, 'lon': 35.04066}}, {'zip': '49005', 'city': 'Dnipro', 'country': 'Ukraine', 'facility': 'Municipal Institution "Dnipropetrovsk Regional Clinical Hospital named after I. I. Mechnikov"', 'geoPoint': {'lat': 48.46664, 'lon': 35.04066}}, {'zip': '76011', 'city': 'Ivano-Frankivsk', 'country': 'Ukraine', 'facility': 'Regional Psyconeurology Hospital #3', 'geoPoint': {'lat': 48.92312, 'lon': 24.71248}}, {'zip': '61068', 'city': 'Kharkiv', 'country': 'Ukraine', 'facility': 'Communal Non-Commercial Enterprise of Kharkiv Regional Council', 'geoPoint': {'lat': 49.98177, 'lon': 36.25475}}, {'zip': '79010', 'city': 'Lviv', 'country': 'Ukraine', 'facility': 'Municipal Institution of Lviv Regional Council', 'geoPoint': {'lat': 49.83826, 'lon': 24.02324}}, {'zip': '46020', 'city': 'Ternopil', 'country': 'Ukraine', 'facility': 'Ternopil Regional Municipal Psychoneurological Hospital', 'geoPoint': {'lat': 49.55404, 'lon': 25.59067}}, {'zip': '21005', 'city': 'Vinnytsia', 'country': 'Ukraine', 'facility': 'Municipal Institution "Vinnytsia Regional Psychoneurological Hospital named after Acad. O.I. Yushch', 'geoPoint': {'lat': 49.2322, 'lon': 28.46871}}], 'overallOfficials': [{'name': 'Sunita Misra, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'SK Life Science, Inc.'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'SK Life Science, Inc.', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}